The new findings strengthen the "RNA world" hypothesis that describes how the first life on Earth could have used RNA instead ...

Aperture Therapeutics is advancing APRTX-003, an RNA-based antisense therapy targeting MMP9, as a potential ALS treatment.

The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...

Veteran immunologist and former Pfizer R&D leader joins Circurna to advance its circular RNA therapeutic platform ...

Researchers from Radboud university medical center and University of Basel have discovered new genetic causes of inherited ...

RNA drugs are a new type of medicine that treat disease by influencing how cells use genetic information, rather than by ...

Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...

The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...

Retinitis pigmentosa (RP) is a genetic eye disorder affecting around one in 5,000 people worldwide. It typically begins with ...

Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...

Advancing RNA therapeutics depends on understanding two critical questions: Where do drug candidates go, and what do they do ...